Larimar Therapeutics Inc. (LRMR) NASDAQ

$6.03 (0.43) (-6.66%)

Market Cap: $412.15M

As of 04/25/24 09:37 AM EDT. Market open.

(LRMR)

Larimar Therapeutics Inc. (LRMR)
NASDAQ

$6.03
(0.43) (-6.66%)

Market Cap: $412.15M

As of 04/25/24 09:37 AM EDT. Market open.

Add to Portfolio

larimar therapeutics, inc. (nasdaq:lrmr), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. the company’s lead compound, cti-1601, is currently being evaluated in a phase 1 clinical program as a potential treatment for friedreich’s ataxia, a rare and progressive genetic disease. larimar also plans to use its intracellular delivery platform ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
Three Bala Plaza East. Suite 506, Pennsylvania, Bala Cynwyd, 19004.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
36
Address
Three Bala Plaza East. Suite 506, Pennsylvania, Bala Cynwyd, 19004.
PRICE CHART FOR LARIMAR THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.03
Previous Close
$6.46
Days Range
$6.33 - $6.50
52 week range
$2.18 - $13.68
Volume
12,564
Avg. Volume (30 days)
377,563
Market Cap
$412.15M
Dividend Yield
-
P/E
-
Shares Outstanding
63,800,017
Open
$6.03
Previous Close
$6.46
Days Range
$6.33 - $6.50
52 week range
$2.18 - $13.68
Volume
12,564
Avg. Volume (30 days)
377,563
Market Cap
$412.15M
Dividend Yield
-
P/E
-
Shares Outstanding
63,800,017
FINANCIAL STATEMENTS FOR LARIMAR THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LARIMAR THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Flynn James EDirectorFeb 16, 2024 Buy$8.741,430,20512,499,9914,207,982Feb 16, 2024, 02:37 PM
Flynn James EDirectorFeb 16, 2024 Buy$8.741,430,20612,500,0006,151,406Feb 16, 2024, 02:37 PM
Flynn James EDirectorFeb 16, 2024 Buy$8.741,430,20612,500,0006,151,389Feb 16, 2024, 02:37 PM
THOMAS FRANK EDirectorFeb 14, 2024 Buy$11.002,00022,0002,000Feb 15, 2024, 04:21 PM
Shankar GopiChief Development OfficerDec 07, 2023 Buy$3.735,00018,6625,000Dec 08, 2023, 04:08 PM
Celano MichaelChief Financial OfficerMay 17, 2023 Buy$3.735,00018,632112,746May 18, 2023, 02:13 PM
BEN-MAIMON CAROLEPresident and CEOMay 17, 2023 Buy$3.705,00018,525266,829May 18, 2023, 02:13 PM
Truitt JosephDirectorMay 17, 2023 Buy$3.732,75010,2582,750May 18, 2023, 02:12 PM
Flynn James EDirectorSep 16, 2022 Buy$3.152,777,7778,749,9982,777,777Sep 20, 2022, 08:31 PM
Flynn James EDirectorSep 16, 2022 Buy$3.152,777,7778,749,9984,721,197Sep 20, 2022, 08:31 PM
Flynn James EDirectorSep 16, 2022 Buy$3.152,777,7778,749,9984,721,200Sep 20, 2022, 08:31 PM
Flynn James EDirectorSep 16, 2022 Buy$3.152,777,7778,749,9984,721,183Sep 20, 2022, 08:31 PM
Hamilton Thomas EdwardDirectorSep 16, 2022 Buy$3.15317,460999,999507,590Sep 20, 2022, 06:54 AM
Celano MichaelChief Financial OfficerSep 16, 2022 Buy$3.1531,746100,00031,746Sep 19, 2022, 07:00 AM
BEN-MAIMON CAROLEPresident and CEOSep 16, 2022 Buy$3.1531,746100,00056,829Sep 19, 2022, 07:00 AM
Flynn James EDirectorJun 30, 2021 Buy$8.75228,5701,999,9881,943,420Jul 02, 2021, 05:07 PM
Flynn James EDirectorJun 30, 2021 Buy$8.75228,5711,999,9961,943,423Jul 02, 2021, 05:07 PM
Flynn James EDirectorJun 30, 2021 Buy$8.75228,5691,999,9791,943,406Jul 02, 2021, 05:07 PM
Hamilton Thomas EdwardDirectorJun 30, 2021 Buy$8.7556,710496,213190,130Jul 02, 2021, 04:08 PM
LAMATTINA JOHN LDirectorJan 24, 2019 Option Exercise$4.3810,84447,49731,376Jan 28, 2019, 07:01 PM
PEREZ ROBERT JDirectorJan 24, 2019 Option Exercise$4.384,42319,3735,322Jan 28, 2019, 07:01 PM
Hughes Thomas E.See RemarksJun 28, 2018 Sale$10.0032,000320,000125,247Jun 29, 2018, 07:01 PM
Hughes Thomas E.See RemarksMar 07, 2018 Sale$10.005,00050,000157,247Mar 09, 2018, 06:00 PM
Daniel Thomas ODirectorJan 03, 2018 Option Exercise$5.188,68744,99919,452Jan 05, 2018, 05:02 PM
LAMATTINA JOHN LDirectorJan 03, 2018 Option Exercise$5.189,16947,49520,532Jan 05, 2018, 05:01 PM
Heller Frances KDirectorOct 13, 2017 Buy$3.9010,00038,98847,961Oct 17, 2017, 05:11 PM
KIM DENNIS DChief Medical OfficerJul 11, 2017 Buy$3.3910,00033,90021,443Jul 12, 2017, 04:05 PM
Hughes Thomas E.President and CEOMay 11, 2017 Option Exercise$0.8093,21174,673157,371May 15, 2017, 08:22 PM
KIM DENNIS DChief Medical OfficerMay 11, 2017 Buy$4.409,80043,12011,443May 11, 2017, 06:59 PM
KIM DENNIS DChief Medical OfficerMay 10, 2017 Buy$4.402008801,643May 11, 2017, 06:59 PM
Daniel Thomas ODirectorFeb 13, 2017 Option Exercise$4.1810,76544,99810,765Feb 14, 2017, 08:14 PM
LAMATTINA JOHN LDirectorFeb 13, 2017 Option Exercise$4.1811,36347,49711,363Feb 14, 2017, 08:07 PM
Heller Frances KDirectorDec 19, 2016 Buy$3.2310,00032,29030,000Dec 20, 2016, 05:02 PM
Heller Frances KDirectorNov 15, 2016 Buy$3.5410,00035,43420,000Nov 17, 2016, 05:00 PM
Hughes Thomas E.President and CEOAug 29, 2016 Buy$3.0010,00029,98763,936Aug 31, 2016, 04:15 PM
Flynn James E10% OwnerJul 20, 2016 Sale$3.31901,4302,985,3561,151,802Aug 01, 2016, 07:14 PM
Flynn James E10% OwnerJul 20, 2016 Sale$3.31246,439816,157314,889Aug 01, 2016, 07:14 PM
Flynn James E10% OwnerJul 20, 2016 Sale$3.31193,630641,264247,413Aug 01, 2016, 07:14 PM
Hughes Thomas E.President and CEOJul 22, 2016 Option Exercise$0.7525,00018,75048,936Jul 26, 2016, 05:14 PM
Hughes Thomas E.President and CEOJul 22, 2016 Buy$3.025,00015,10453,936Jul 26, 2016, 05:14 PM
Allen Patricia LChief Financial OfficerJul 26, 2016 Buy$3.158,20025,83019,793Jul 26, 2016, 05:10 PM
Allen Patricia LChief Financial OfficerJul 25, 2016 Buy$3.087,80024,03211,593Jul 26, 2016, 05:10 PM
Heller Frances KDirectorJul 22, 2016 Buy$2.9910,00029,90010,000Jul 26, 2016, 05:09 PM
PEREZ ROBERT JDirectorJan 07, 2016 Option Exercise$6.295,56434,9985,564Apr 12, 2016, 09:00 PM
McDonough Cameron GeoffreyDirectorApr 01, 2016 Option Exercise$7.914,42434,9940Apr 04, 2016, 09:00 PM
Flynn James E10% OwnerFeb 12, 2016 Buy$6.2513,87286,6532,053,232Feb 17, 2016, 02:02 PM
Flynn James E10% OwnerFeb 12, 2016 Buy$6.2528,377177,260561,328Feb 17, 2016, 02:02 PM
Flynn James E10% OwnerFeb 12, 2016 Buy$6.2522,296139,274441,043Feb 17, 2016, 02:02 PM
Flynn James E10% OwnerFeb 10, 2016 Buy$6.2332,501202,5562,038,856Feb 11, 2016, 08:21 PM
Flynn James E10% OwnerFeb 10, 2016 Buy$6.2366,486414,361531,921Feb 11, 2016, 08:21 PM
Flynn James E10% OwnerFeb 10, 2016 Buy$6.2352,239325,569417,937Feb 11, 2016, 08:21 PM
Flynn James E10% OwnerFeb 09, 2016 Buy$5.7324,484140,2712,006,355Feb 11, 2016, 08:21 PM
Flynn James E10% OwnerFeb 11, 2016 Buy$6.195043,1192,039,360Feb 11, 2016, 08:21 PM
Flynn James E10% OwnerFeb 09, 2016 Buy$5.7350,086286,948465,435Feb 11, 2016, 08:21 PM
Flynn James E10% OwnerFeb 11, 2016 Buy$6.191,0306,374532,951Feb 11, 2016, 08:21 PM
Flynn James E10% OwnerFeb 09, 2016 Buy$5.7339,353225,457365,698Feb 11, 2016, 08:21 PM
Flynn James E10% OwnerFeb 11, 2016 Buy$6.198105,013418,747Feb 11, 2016, 08:21 PM
Barrett PeterDirectorJan 25, 2016 Option Exercise$7.918,84969,9964,643,327Jan 27, 2016, 09:19 PM
McDonough Cameron GeoffreyDirectorJan 25, 2016 Option Exercise$7.914,42434,9944,424Jan 27, 2016, 09:18 PM
Booth BruceDirectorJan 25, 2016 Option Exercise$7.914,42434,9944,638,028Jan 27, 2016, 09:18 PM
Hughes Thomas E.Chief Executive OfficerJan 08, 2016 Option Exercise$0.7510,0007,50021,320Jan 08, 2016, 06:53 PM
PEREZ ROBERT JDirectorOct 28, 2015 Option Exercise$10.458999,395899Oct 30, 2015, 05:01 PM
KIM DENNIS DChief Medical OfficerSep 17, 2015 Sale$40.009,142365,6800Oct 20, 2015, 08:01 PM
KIM DENNIS DChief Medical OfficerSep 15, 2015 Sale$40.0030,2651,210,6000Oct 20, 2015, 08:01 PM
KIM DENNIS DChief Medical OfficerSep 14, 2015 Sale$40.0059323,7200Oct 20, 2015, 08:00 PM
STARR KEVIN PDirectorSep 24, 2015 Sale$43.90136,5795,995,403272,001Sep 25, 2015, 04:38 PM
Hughes Thomas E.Chief Executive OfficerSep 23, 2015 Option Exercise$0.7510,5007,87511,320Sep 24, 2015, 09:00 PM
Hughes Thomas E.Chief Executive OfficerSep 18, 2015 Option Exercise$2.4523,12656,65923,946Sep 21, 2015, 09:02 PM
Hughes Thomas E.Chief Executive OfficerSep 17, 2015 Option Exercise$2.454,87411,94123,320Sep 21, 2015, 09:02 PM
Hughes Thomas E.Chief Executive OfficerSep 17, 2015 Sale$40.0022,500900,000820Sep 21, 2015, 09:02 PM
Hughes Thomas E.Chief Executive OfficerSep 18, 2015 Sale$45.0023,1261,040,670820Sep 21, 2015, 09:02 PM
Goldberg Avi Y.DirectorSep 18, 2015 Sale$45.005,000225,00053,734Sep 21, 2015, 09:01 PM
Secor AliciaChief Commercial OfficerSep 17, 2015 Option Exercise$9.6725,000241,75026,256Sep 21, 2015, 09:00 PM
Secor AliciaChief Commercial OfficerSep 17, 2015 Sale$41.0526,2561,077,8091,256Sep 21, 2015, 09:00 PM
KIM DENNIS DChief Medical OfficerSep 17, 2015 Option Exercise$1.579,14214,3539,142Sep 17, 2015, 09:00 PM
KIM DENNIS DChief Medical OfficerSep 15, 2015 Option Exercise$1.5730,26547,51630,265Sep 17, 2015, 09:00 PM
KIM DENNIS DChief Medical OfficerSep 17, 2015 Sale$40.009,142365,6800Sep 17, 2015, 09:00 PM
KIM DENNIS DChief Medical OfficerSep 15, 2015 Sale$40.0030,2651,210,6000Sep 17, 2015, 09:00 PM
KIM DENNIS DChief Medical OfficerSep 14, 2015 Option Exercise$1.57593931593Sep 16, 2015, 09:48 PM
KIM DENNIS DChief Medical OfficerSep 14, 2015 Sale$40.0059323,7200Sep 16, 2015, 09:48 PM
Goldberg Avi Y.DirectorJun 10, 2015 Sale$35.003,000105,00058,734Jun 12, 2015, 06:24 PM
Goldberg Avi Y.DirectorJun 01, 2015 Sale$32.232,00064,45261,734Jun 03, 2015, 07:05 PM
STARR KEVIN PDirectorJan 08, 2015 Option Exercise$40.041,24849,9709,356Jan 12, 2015, 07:44 PM
Booth BruceDirectorJan 08, 2015 Option Exercise$40.0487434,9955,633,604Jan 12, 2015, 07:41 PM
Barrett PeterDirectorJan 08, 2015 Option Exercise$40.041,74869,9905,634,478Jan 12, 2015, 07:39 PM
Secor AliciaChief Commercial OfficerJun 19, 2014 Buy$20.004,00080,0004,000Jun 23, 2014, 05:52 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Flynn James EDirector02/16/202412,499,991
Flynn James EDirector02/16/202412,500,000
Flynn James EDirector02/16/202412,500,000
THOMAS FRANK EDirector02/14/202422,000
Shankar GopiChief Development Officer12/07/202318,662
Celano MichaelChief Financial Officer05/17/202318,632
BEN-MAIMON CAROLEPresident and CEO05/17/202318,525
Truitt JosephDirector05/17/202310,258
Flynn James EDirector09/16/20228,749,998
Flynn James EDirector09/16/20228,749,998
Flynn James EDirector09/16/20228,749,998
Flynn James EDirector09/16/20228,749,998
Hamilton Thomas EdwardDirector09/16/2022999,999
Celano MichaelChief Financial Officer09/16/2022100,000
BEN-MAIMON CAROLEPresident and CEO09/16/2022100,000
Flynn James EDirector06/30/20211,999,988
Flynn James EDirector06/30/20211,999,996
Flynn James EDirector06/30/20211,999,979
Hamilton Thomas EdwardDirector06/30/2021496,213
LAMATTINA JOHN LDirector01/24/201947,497
PEREZ ROBERT JDirector01/24/201919,373
Hughes Thomas E.See Remarks06/28/2018320,000
Hughes Thomas E.See Remarks03/07/201850,000
Daniel Thomas ODirector01/03/201844,999
LAMATTINA JOHN LDirector01/03/201847,495
Heller Frances KDirector10/13/201738,988
KIM DENNIS DChief Medical Officer07/11/201733,900
Hughes Thomas E.President and CEO05/11/201774,673
KIM DENNIS DChief Medical Officer05/11/201743,120
KIM DENNIS DChief Medical Officer05/10/2017880
Daniel Thomas ODirector02/13/201744,998
LAMATTINA JOHN LDirector02/13/201747,497
Heller Frances KDirector12/19/201632,290
Heller Frances KDirector11/15/201635,434
Hughes Thomas E.President and CEO08/29/201629,987
Flynn James E10% Owner07/20/20162,985,356
Flynn James E10% Owner07/20/2016816,157
Flynn James E10% Owner07/20/2016641,264
Hughes Thomas E.President and CEO07/22/201618,750
Hughes Thomas E.President and CEO07/22/201615,104
Allen Patricia LChief Financial Officer07/26/201625,830
Allen Patricia LChief Financial Officer07/25/201624,032
Heller Frances KDirector07/22/201629,900
PEREZ ROBERT JDirector01/07/201634,998
McDonough Cameron GeoffreyDirector04/01/201634,994
Flynn James E10% Owner02/12/201686,653
Flynn James E10% Owner02/12/2016177,260
Flynn James E10% Owner02/12/2016139,274
Flynn James E10% Owner02/10/2016202,556
Flynn James E10% Owner02/10/2016414,361
Flynn James E10% Owner02/10/2016325,569
Flynn James E10% Owner02/09/2016140,271
Flynn James E10% Owner02/11/20163,119
Flynn James E10% Owner02/09/2016286,948
Flynn James E10% Owner02/11/20166,374
Flynn James E10% Owner02/09/2016225,457
Flynn James E10% Owner02/11/20165,013
Barrett PeterDirector01/25/201669,996
McDonough Cameron GeoffreyDirector01/25/201634,994
Booth BruceDirector01/25/201634,994
Hughes Thomas E.Chief Executive Officer01/08/20167,500
PEREZ ROBERT JDirector10/28/20159,395
KIM DENNIS DChief Medical Officer09/17/2015365,680
KIM DENNIS DChief Medical Officer09/15/20151,210,600
KIM DENNIS DChief Medical Officer09/14/201523,720
STARR KEVIN PDirector09/24/20155,995,403
Hughes Thomas E.Chief Executive Officer09/23/20157,875
Hughes Thomas E.Chief Executive Officer09/18/201556,659
Hughes Thomas E.Chief Executive Officer09/17/201511,941
Hughes Thomas E.Chief Executive Officer09/17/2015900,000
Hughes Thomas E.Chief Executive Officer09/18/20151,040,670
Goldberg Avi Y.Director09/18/2015225,000
Secor AliciaChief Commercial Officer09/17/2015241,750
Secor AliciaChief Commercial Officer09/17/20151,077,809
KIM DENNIS DChief Medical Officer09/17/201514,353
KIM DENNIS DChief Medical Officer09/15/201547,516
KIM DENNIS DChief Medical Officer09/17/2015365,680
KIM DENNIS DChief Medical Officer09/15/20151,210,600
KIM DENNIS DChief Medical Officer09/14/2015931
KIM DENNIS DChief Medical Officer09/14/201523,720
Goldberg Avi Y.Director06/10/2015105,000
Goldberg Avi Y.Director06/01/201564,452
STARR KEVIN PDirector01/08/201549,970
Booth BruceDirector01/08/201534,995
Barrett PeterDirector01/08/201569,990
Secor AliciaChief Commercial Officer06/19/201480,000
Load More Insider Transactions
FUNDS WITH A POSITION IN LARIMAR THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)21,231,9743.42%25.33%Other
BLACKROCK INC.1,668,0450.00019%10.55%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.1,276,6800.01%8.5%Other
GEODE CAPITAL MANAGEMENT, LLC647,7180.00031%5.1%Other
UBS OCONNOR LLC319,9010.1%-15.48%Value
RENAISSANCE TECHNOLOGIES LLC247,0420.00174%0.69%Other
CHANGE IN SHARES OUTSTANDING FOR LARIMAR THERAPEUTICS INC
STOCK BUYBACKS FOR LARIMAR THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.01%
1Q
12/31/2023
06/30/2023
0.02%
2Q
12/31/2023
03/31/2023
0.02%
3Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.01%
1Q
06/30/2023
0.02%
2Q
03/31/2023
0.02%
3Q
BUYBACK ANNOUNCEMENT(S) FOR LARIMAR THERAPEUTICS INC
LOADING...